$NVLX According to the American cancer Society, in the US

New Post Public Reply Private Reply Replies (0) Message Board

Mar 21, 2014 at 8:51 AM

$NVLX According to the American cancer Society, in the US alone, approximately 45,000 new cases of pancreatic cancer are expected to be diagnosed this year and about 38,000 people are predicted to die from the disease; it is the leading cause of cancer deaths in the US and worldwide. Often pancreatic cancer is not diagnosed until it has reached an advanced stage. By this time, the cancer cannot be removed surgically, is often resistant to radiation therapy or chemotherapy, and has spread (metastasized) to other organs in the body. Because of this, the average survival of patients with advanced, inoperable pancreatic cancer is given in terms of weeks or months, not years.Nuvilex’s pancreatic cancer treatment consists of the use of a proprietary cellulose-based live-cell encapsulation technology together with the long-known and widely used anticancer drug ifosfamide.In a Phase I/II open-label, prospective, single-arm clinical trial, the live-cell encapsulation/ifosfamide combination was used to treat patients with advanced, inoperable pancreatic cancer. Fifty-one patients were originally “screened” for the trial; of these, 17 were enrolled in the study. Other patients were excluded from enrollment for therapy because of previous chemotherapy, previous pancreatic surgery, poor overall health, unwillingness to participate, or death prior to the start of the trial. Of the 17 patients initially enrolled in the study, 14 were ultimately treated. Results obtained in the clinical trial were compared with historical data for gemcitabine and included: median survival time of 44 weeks (after diagnosis) with the cell encapsulation/ifosfamide treatment as compared to 28 weeks with gemcitabine; doubling of the one-year survival rate – 36% with our treatment vs. 18% with gemcitabine; tumor volume was reduced 25-50% in 4 of the 14 treated patients and remained stable in the remaining patients; no serious drug-related side effects with the encapsulated cell/ifosfamide treatment whereas serious and very serious side effects were reported with gemcitabine; the lack of serious side effects using our treatment is probably related to the use of “lower than normal” doses of ifosfamide; limited side effects and reduced cancer pain intensity led to a generally increased ‘quality of life” for the majority of patients. In a “worst case” scenario, some clinical benefit was seen in 50% of patients and in a “best case” scenario, this number increased to 71%; none of the patients who experienced a clinical benefit required and increase in their pain medication.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ping Identity Tops 2026 Gartner Magic Quadrant: CIAM

Turning Heads in the Cybersecurity Space When it comes to digital security, Ping Identity has snagged a top spot in Gartner's 2026 Magic Quadrant for Customer Identity and Access Management (CIAM). Some might gloss over these annual reports like yesterday's news, but Ping isn't just playing around here. They've been tapped as a Leader again, and this accolade highlights...

Neuberger Fund Ups Distribution Amid Market Challenges

Neuberger Boosts Distribution: What's Driving This? I ain't about to sugarcoat it: the Neuberger Next Generation Connectivity Fund (NYSE: NBXG) decided to jack up its monthly distribution rate to $0.132 per share. This announcement, hitting wallets on November 30, 2026, has a record and ex-date of November 16. Now, that's a good ol' reliable payout for folks holding NBXG...

Lepage Millwork to Acquire Custom Window Maker Fenêtres MQ

Big Move in Windows: Lepage Eyes Fenêtres MQ Dust off those old window ledgers, folks, because we've got a shake-up in the custom luxury window game. Lepage Millwork, a family-run titan in the North American fenestration scene, is gearing up to take over Fenêtres MQ from the big shots over at Andersen. We're talking about an ownership shift set to seal the deal by...

Excellence Award Celebrates Medicilon-Revolution Partnership

Breaking the 'Undruggable' Myth Out there in the trenches of drug discovery, this Medicilon and Revolution Medicines partnership has been stirring up some waves. Now, I ain't talking about your daily Wall Street hubbub, but a three-year grind that's led to something seriously noteworthy: turning the so-called 'undruggable' KRAS target into a real game-changer. Pan-KRAS...

HK Reforms Unveiled Post-Devastating Fire: A Closer Look

Unpacking Hong Kong's Response to Unthinkable Tragedy Ever been in front of a thick, burning building façade, watching helplessly as it all crumbles away? Well, that's what happened in Hong Kong last year on November 26. A devastating fire at Wang Fuk Court in Tai Po turned lives upside down, killing 168 people, and it's prodded the government to finally sit up and...

HIMS Faces Class Action Over Alleged Privacy Violations

Got a thing for drama in the world of stocks? Well, listen up. Hims & Hers Health, Inc., the darling of digital health on the NYSE, is up to its eyeballs in a fresh securities fraud class action lawsuit over some seriously questionable practices. If you got skin in this game with HIMS between August 4, 2025, and July 29, 2026, you've got a deadline staring you down:...

Z Squared Eyes 150 MW Expansion at Arkansas Site

Turning Power into Potential at Union County Next stop, Union County, Arkansas. Z Squared Inc. (Nasdaq: ZSQR) isn't just talking shop; they're getting down to work. With a freshly acquired site through Paradox Data, LLC, Z Squared's planning to turn vision into reality. The site's already armed with 8 MW of juice, all ready to roll, but their ambitions shoot up to 150 MW...

Endava's Securities Class Action Heats Up Wall Street

A Head-Spinning Fall for Endava Endava's recent tumble on the NYSE has investors rubbing their eyes in disbelief. A jaw-dropping 25% slide in share value on September 22, 2026, has everyone scrambling for answers. Looks like some serious skeletons were hiding deep in Endava's closets—management snafus and fuzzy accounting being at the forefront. This debacle has peeled...

Buyers Edge Appoints Sam Peterson as CTO to Lead AI Shift

Anticipating a New Era of AI with Buyers Edge The rumble through the procurement world was more of a jolt this week as Buyers Edge Platform (BEP) threw a new player into the tech gauntlet. Sam Peterson has been handed the reins as the Chief Technology Officer. The goal? To supercharge BEP's innovation engine with some AI-driven gusto. What's in the Cards for Buyers Edge...

Mazu Culture Forum Unveils New Initiatives in China

A Cultural Tapestry Unfurls in Putian Picture this: a kaleidoscope of cultures and ideas unraveling in the coastal city of Putian. The 11th Global Mazu Culture Forum kicks off on October 31, bringing together minds—both fresh and seasoned—from an impressive array of 47 countries and regions. It's more than a forum; it's a vibrant crossroads of innovation, tradition,...

Top 5 Most Recently Viewed Articles

Qualcomm's New AI Chips: Analysts Share Their Diverging Views

Qualcomm Enters the Competitive AI Chip Market As Qualcomm Inc. (NASDAQ: QCOM) steps into the AI chip market, analysts are sharing a mix of expectations. Some see it as a strategic move to disrupt NVIDIA Corp.'s (NASDAQ: NVDA) stronghold, while others view it with skepticism. This landscape is rapidly evolving, and the impact of Qualcomm's latest innovations is yet to be...

€54 Million Investment to Boost AGCO Power's Production Capacity

New Developments in AGCO Power's Manufacturing Facilities AGCO (NYSE: AGCO) recently made headlines with a significant €54 million investment aimed at enhancing its AGCO Power™ production facilities in Linnavuori, Finland. This move is more than just an expansion; it's a strategic decision that underscores AGCO's commitment to sustainability and its integral role in...

Smart Strategies for Reducing Winter Heating Expenses

Essential Tips for Lowering Winter Heating Costs As New Jersey begins to experience colder temperatures, households are likely to face higher electric bills, specifically concerning home heating systems. Understanding how to mitigate these costs can be a game-changer for families trying to stay warm during the winter months. Anton Plumbing Heating & Cooling encourages...

Service Corporation International's Q3 Performance Report: Growth Insights

Service Corporation International Reports Steady Growth Service Corporation International (SCI), a prominent entity in the funeral and cemetery services sector, has showcased a solid performance with an increase in adjusted earnings per share (EPS) to $0.79 for the third quarter. Compared to the previous year, where adjusted EPS stood at $0.78, this marks a positive trend...

Aya Gold & Silver Secures Funding for Boumadine Project Growth MONTREAL — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) is thrilled to share exciting news regarding its Boumadine polymetallic project, a venture poised to transform minerals extraction in Morocco. The company has successfully closed a US$25 million credit facility with the European Bank for...